201 related articles for article (PubMed ID: 7365253)
21. Activation of rat alveolar macrophages to the tumoricidal state in the presence of progressively growing pulmonary metastases.
Sone S; Fidler IJ
Cancer Res; 1981 Jun; 41(6):2401-6. PubMed ID: 7237438
[TBL] [Abstract][Full Text] [Related]
22. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
Schroit AJ; Fidler IJ
Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
[TBL] [Abstract][Full Text] [Related]
23. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
[TBL] [Abstract][Full Text] [Related]
24. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
[TBL] [Abstract][Full Text] [Related]
25. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
Ogura T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
[TBL] [Abstract][Full Text] [Related]
26. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
[TBL] [Abstract][Full Text] [Related]
27. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
[TBL] [Abstract][Full Text] [Related]
28. Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.
Kleinerman ES; Schroit AJ; Fogler WE; Fidler IJ
J Clin Invest; 1983 Jul; 72(1):304-15. PubMed ID: 6348087
[TBL] [Abstract][Full Text] [Related]
29. In vitro induction of cytotoxic polymorphonuclear leukocytes by supernatant from a concanavalin A-stimulated spleen cell culture.
Inoue T; Sendo F
J Immunol; 1983 Nov; 131(5):2508-14. PubMed ID: 6605388
[TBL] [Abstract][Full Text] [Related]
30. In vivo and in vitro NO2 exposures enhance phagocytic and tumoricidal activities of rat alveolar macrophages.
Sone S; Brennan LM; Creasia DA
J Toxicol Environ Health; 1983 Jan; 11(1):151-63. PubMed ID: 6827622
[TBL] [Abstract][Full Text] [Related]
31. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
Sone S; Mutsuura S; Ogawara M; Tsubura E
J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
[TBL] [Abstract][Full Text] [Related]
32. Stimulatory effect of vitamin A on tumoricidal activity of rat alveolar macrophages.
Tachibana K; Sone S; Tsubura E; Kishino Y
Br J Cancer; 1984 Mar; 49(3):343-8. PubMed ID: 6704311
[TBL] [Abstract][Full Text] [Related]
33. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
Schultz RM; Chirigos MA
Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
[TBL] [Abstract][Full Text] [Related]
34. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
Meltzer MS; Benjamin WR; Farrar JJ
J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
[TBL] [Abstract][Full Text] [Related]
35. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity in the sensitivities of the 13762NF rat mammary adenocarcinoma cell clones to cytolysis mediated by extra- and intratumoral macrophages.
North SM; Nicolson GL
Cancer Res; 1985 Apr; 45(4):1453-8. PubMed ID: 3978611
[TBL] [Abstract][Full Text] [Related]
37. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
Taramelli D; Holden HT; Varesio L
J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
[TBL] [Abstract][Full Text] [Related]
38. The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.
Poste G
Am J Pathol; 1979 Aug; 96(2):595-610. PubMed ID: 382866
[TBL] [Abstract][Full Text] [Related]
39. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
Fortner GW; Kuperman O; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
[TBL] [Abstract][Full Text] [Related]
40. Activation of tumoricidal properties in macrophages by lymphokines encapsulated in liposomes.
Fidler IJ; Fogler WE
Lymphokine Res; 1982; 1(3):73-7. PubMed ID: 6765335
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]